Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Lets support each other in becoming the best versions of ourselves
What worries me most is what patients will reasonably conclude
Personalized Care Every protocol is designed around your specific health goals, injury history, and recovery timeline
If you are comparing the two for your protocol, the side effect profiles and dosage equivalencies are covered in separate guides
TB-500 and Thymosin Beta-4 are also prohibited by WADA/USADA under S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), applicable at all times both in-competition and out-of-competition TB-500 / Thymosin Beta-4 Clinical Trials: The RGN-352 and RGN-259 Programs RegeneRx Biopharmaceuticals has pursued two clinical development programs for Thymosin Beta-4, providing the most substantial human clinical data available for any TB-500-related compound: RGN-352 (Injectable Thymosin Beta-4 for Cardiac Repair): Phase 1 trial (completed): A double-blind, placebo-controlled study enrolled 40 healthy volunteers across four cohorts of 10 subjects each, testing escalating dose levels of intravenous Thymosin Beta-4 administered daily over 14 days
MIC/B12 injections are considered safe when administered by a qualified practitioner
US$ 25.90
US$ 24.08
US$ 26.55
